{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:20:54Z","timestamp":1787764854061,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>We aimed to evaluate the effect of shock wave therapy on the improvement of symptoms and function of patients with Dupuytren's contracture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This research is a pre-post intervention study, conducted among patients referred to the physical medicine clinics of Isfahan during 2019\u20132020. In this study, subjects experienced shock wave therapy for 6 sessions, each in a week, and improvement of symptoms and function were assessed and compared after the period of study and follow-up (before treatment, 6 weeks after treatment, and 14 weeks after treatment). The pain visual analog scale and disabilities of the arm shoulder and hand questionnaire were completed for all patients at the mentioned time, and the finger contraction angle was also measured by a goniometer over these intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty patients, 11 (55%) men and 9 (45%) women participated in the study. The mean and standard deviation of their age was 66.6 \u00b1 7.11 years. The trend of pain severity of patients was continuously and significantly decreasing up to 14 weeks, which implies the effectiveness of the intervention (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Moreover, the patients\u2019 functional status improved due to the continuation of the intervention, and its trend was decreasing up to 14 weeks (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). As for the contraction angle, there was a continuous and significant decreasing trend until week 14, and the intervention was also effective on the contraction angle (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>It can be concluded that shock wave therapy can be effective in improving the symptoms and function of patients with Dupuytren's Contracture.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_155_21","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T02:17:24Z","timestamp":1698373044000},"page":"3","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["The Effect of Shock Wave Therapy on Improving the Symptoms and Function of Patients with Dupuytren's Contracture"],"prefix":"10.4103","volume":"11","author":[{"given":"Parisa","family":"Taheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Maghroori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20240830","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/1753193417715773","article-title":"Dupuytren's disease: My personal view","volume":"42","author":"Warwick","year":"2017","journal-title":"J Hand Surg Eur Vol"},{"key":"R2-3-20240830","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase Clostridium histolyticum for Dupuytren's contracture","volume":"361","author":"Hurst","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-3-20240830","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11552-010-9306-4","article-title":"Prevalence, incidence, and treatments of Dupuytren's disease in the United States: Results from a population-based study","volume":"6","author":"DiBenedetti","year":"2011","journal-title":"Hand (N Y"},{"key":"R4-3-20240830","first-page":"285","article-title":"Evaluation of the effects of fasciectomy on finger contracture in patients with Dupuytren's disease","volume":"35","author":"Zarezadeh","year":"2017","journal-title":"J Isfahan Med Sch"},{"key":"R5-3-20240830","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3121\/cmr.2012.1063","article-title":"Evaluation of a mitochondrial DNA mutation in maternally inherited and sporadic cases of Dupuytren's disease","volume":"10","author":"Anderson","year":"2012","journal-title":"Clin Med Res"},{"key":"R6-3-20240830","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/J.JHSB.2004.06.006","article-title":"Dupuytren's disease risk factors","volume":"29","author":"Geoghegan","year":"2004","journal-title":"J Hand Surg"},{"key":"R7-3-20240830","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11552-007-9076-9","article-title":"Gender ratio of Dupuytren's disease in the modern U.S. population","volume":"3","author":"Anthony","year":"2008","journal-title":"Hand (N Y"},{"key":"R8-3-20240830","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jhsa.2006.08.012","article-title":"Factors in the pathogenesis of Dupuytren's contracture","volume":"31","author":"Al-Qattan","year":"2006","journal-title":"J Hand Surg Am"},{"key":"R9-3-20240830","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","article-title":"Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology","volume":"4","author":"Hindocha","year":"2009","journal-title":"Hand (N Y"},{"key":"R10-3-20240830","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13018-020-01999-7","article-title":"The worldwide prevalence of the Dupuytren disease: A comprehensive systematic review and meta-analysis","volume":"15","author":"Salari","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"R12-3-20240830","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jhsa.2015.10.027","article-title":"Clusters in short-term disease course in participants with primary Dupuytren disease","volume":"41","author":"Lanting","year":"2016","journal-title":"J Hand Surg Am"},{"key":"R13-3-20240830","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clindermatol.2019.07.027","article-title":"Dupuytren contracture as a sign of systemic disease","volume":"37","author":"Bogdanov","year":"2019","journal-title":"Clin Dermatol"},{"key":"R14-3-20240830","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.hcl.2018.03.009","article-title":"Treatment of recurrent Dupuytren disease","volume":"34","author":"Kaplan","year":"2018","journal-title":"Hand Clin"},{"key":"R15-3-20240830","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.hcl.2018.03.006","article-title":"Comparative outcomes of Dupuytren disease treatment","volume":"34","author":"Binhammer","year":"2018","journal-title":"Hand Clin"},{"key":"R16-3-20240830","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jhsa.2008.05.027","article-title":"Nonoperative treatment of Dupuytren's disease","volume":"33","author":"Rayan","year":"2008","journal-title":"J Hand Surg Am"},{"key":"R17-3-20240830","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hcl.2018.03.007","article-title":"Complications of treatment for Dupuytren disease","volume":"34","author":"Eberlin","year":"2018","journal-title":"Hand Clin"},{"key":"R18-3-20240830","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/PRS.0000000000007243","article-title":"Collagenase treatment of Dupuytren's disease with minimum 5-year follow-up: Recurrence, reintervention, and satisfaction","volume":"146","author":"Zhang","year":"2020","journal-title":"Plast Reconstr Surg"},{"key":"R19-3-20240830","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00066-010-2063-z","article-title":"Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years","volume":"186","author":"Betz","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"R20-3-20240830","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.mehy.2011.01.018","article-title":"Focused extracorporeal shockwave therapy in Dupuytren's disease \u2013 A hypothesis","volume":"76","author":"Knobloch","year":"2011","journal-title":"Med Hypotheses"},{"key":"R21-3-20240830","first-page":"124","article-title":"Extracorporeal shock wave therapy in Dupuytren's disease","volume":"52","author":"Aykut","year":"2018","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"R22-3-20240830","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4055\/jkoa.2018.53.5.400","article-title":"Extracorporeal shock wave therapy in musculoskeletal disorders","volume":"53","author":"Yum","year":"2018","journal-title":"J Korean Orthop Assoc"},{"key":"R23-3-20240830","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2106\/JBJS.17.00661","article-title":"The role of extracorporeal shockwave treatment in musculoskeletal disorders","volume":"100","author":"Moya","year":"2018","journal-title":"J Bone Joint Surg Am"},{"key":"R24-3-20240830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5662\/wjm.v8.i3.37","article-title":"Can extracorporeal shock-wave therapy be used for the management of lateral elbow tendinopathy?","volume":"8","author":"Stasinopoulos","year":"2018","journal-title":"World J Methodol"},{"key":"R25-3-20240830","first-page":"862","article-title":"High-energy focused extracorporeal shockwave therapy relieved pain in Dupuytren's disease: A series of seven hands","volume":"55","author":"Abdulsalam","year":"2019","journal-title":"Eur J Phys Rehabil Med"},{"key":"R26-3-20240830","first-page":"64","article-title":"The survey and comparison of musculoskeletal disorders of shoulder, arm and hand in taxi and bus drivers in the city of Shiraz in 2016","volume":"19","author":"Taghizadeh","year":"2018","journal-title":"Arch Rehabil"},{"key":"R27-3-20240830","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0269215508085821","article-title":"Cultural adaptation and validation of the persian version of the disabilities of the arm, shoulder and hand (DASH) outcome measure","volume":"22","author":"Mousavi","year":"2008","journal-title":"Clin Rehabil"},{"key":"R28-3-20240830","first-page":"10","article-title":"correlation between pain intensity and disability level with some of the impairments in patients with nonspecific low back pain","volume":"21","author":"Zahednezhad","year":"2013","journal-title":"J Ilam Univ Med Sci"},{"key":"R29-3-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-016-1200-y","article-title":"Systematic review of non-surgical treatments for early Dupuytren's disease","volume":"17","author":"Ball","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"R30-3-20240830","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/1097-0142(19920515)69:10<2478::AID-CNCR2820691016>3.0.CO;2-V","article-title":"Clinical and cellular effects of colchicine in fibromatosis","volume":"69","author":"Dominguez-Malagon","year":"1992","journal-title":"Cancer"},{"key":"R31-3-20240830","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/00004623-195941040-00008","article-title":"Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management","volume":"41-A","author":"Luck","year":"1959","journal-title":"J Bone Joint Surg Am"},{"key":"R32-3-20240830","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/jhsu.2000.6918","article-title":"Enzyme injection as nonsurgical treatment of Dupuytren's disease","volume":"25","author":"Badalamente","year":"2000","journal-title":"J Hand Surg Am"},{"key":"R33-3-20240830","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.jhsa.2012.06.032","article-title":"Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: The importance of clear definitions","volume":"37","author":"Werker","year":"2012","journal-title":"J Hand Surg Am"},{"key":"R34-3-20240830","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11552-011-9326-8","article-title":"A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture","volume":"6","author":"Chen","year":"2011","journal-title":"Hand (N Y"},{"key":"R35-3-20240830","first-page":"124","article-title":"Extracorporeal shock wave therapy in Dupuytren's disease","volume":"52","author":"Aykut","year":"2018","journal-title":"Sisli Etfal Hastan Tip Bul"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_155_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:48:11Z","timestamp":1787762891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_155_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/abr.abr_155_21","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}